Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery

• Status: Recruiting
• Trial end date: 2023-06-30
• Target enrollment: 0
• Participant gender: All

Summary

The primary purpose of this three-arm single center, randomized, subject and assessor blind, controlled clinical study is to evaluate the effect of dexmedetomidine on patient-controlled intravenous analgesia after pediatric scoliosis orthopedics.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Peking Union Medical College Hospital
• Treatments: Dexmedetomidine; Dsuvia; Sufentanil

Criteria

Inclusion Criteria:

• Aged 1-14 years scheduled to receive scoliosis orthopedics under general anesthesia;

• Weight is ±15% of standard weight (standard weight (kg) = height (cm) -100);

• Informed consent signed.

Exclusion Criteria:

• Allergy to dexmedetomidine;

• Obvious abnormalities of heart, lung, liver, renal function and endocrine function;

• Patients who can not cooperate with this trial.